ACI 2019 - Exhibitors

Advanced Cardiovascular Intervention 2019 - Exhibitors

For details regarding exhibiting at ACI 2019, please contact Millbrook Medical Conferences on 01455 552559 or email

Diamond Sponsors



From essential vascular devices to next-generation technologies, our products are helping lay the foundation for better health outcomes every day. Minimally invasive treatments help speed recovery and let people get back to their daily activities faster with fewer complications, allowing healthier lives for millions of people worldwide.

We’re dedicated to advancing patient care by transforming the treatment of vascular disease through medical device innovations, investments in research and development, and physician training and education. We have an industry-leading pipeline and comprehensive portfolio of products for cardiac and vascular care. And we’re committed to developing innovative technologies that have the potential to change the way physicians treat vascular disease.



 Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  Boston Scientific’s Interventional Cardiology division provides technologies for diagnosing and treating coronary artery disease, structural heart diseases and other cardiovascular disorders.



As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations, and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes. Join us in our commitment to take healthcare Further, Together. Learn more at




Cordis is a leader in the development and manufacture of interventional vascular technology with a more than 50-year history of delivering pioneering products to treat millions of patients worldwide. Cordis is committed to delivering the right combination of products, services and evidence to our customers and the patients they serve.

We look forward to meeting you at ACI to discuss and share the latest updates on Cordis Cardiovascular portfolio including the EluNIR™ Drug Eluting Stent, the new RAIN Sheath™, RAILWAY™ Sheathless Access system and Kaneka PTCA Balloons.



Minimising vessel trauma is Terumo’s core objective. Our leading edge TRI access and delivery systems allow cardiologists to perform procedures in a safer, faster and more comfortable way.

Terumo’s comprehensive portfolio includes the Ultimaster ™ Tansei Drug-Eluting Stent a range of balloon catheters, Ryujin ™, Accuforce ™ and Tazuna ™.     An extensive range of diagnostic catheters, unique microcatheters Finecross ™ & Dual Lumen microcatheter Fineduo ™, Runthrough ™ guidewires and a thrombo-aspiration device Eliminate ™. Not forgetting Terumo’s extensive introducer sheath range including Glidesheath Slender ™

From simple to challenging cases, Terumo’s products deliver outstanding performance.



Philips Image Guided Therapy

As the leader in image guided therapy, we are committed to working with healthcare providers to help improve treatment for every patient. Our vision is to provide integrated solutions that advance minimally invasive procedures by helping healthcare providers to decide, guide, treat and confirm the right therapy for the right patient at the point of care. Working together to realize this vision, we can save and improve lives and reduce the total cost of care.



Vascular Perspectives Ltd specialise in promoting unique and innovative products for use in interventional cardiology. Our representatives work throughout the United Kingdom providing high-level sales and educational support for clinical teams. We believe education is a critical component that allows clinicians to make the correct equipment choice and maximise procedural success. Working in partnership with key opinion leaders to communicate new ideas and techniques, we design informative educational programmes to support both products and procedures.



AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory & Autoimmunity, Cardiovascular & Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.



Biosensors International aims to improve patients’ lives through pioneering medical technology.

Featuring our proprietary anti-restenotic drug Biolimus A9™, polymer and carrier free BioFreedom™ is the only commercially available stent approved for ultra-short 1 month DAPT in HBR patients.

A proven solution* enabling tailored DAPT to meet individual patients’ needs, down to 1 month.

(*LEADERS FREE clinical trial (NEJM October 26th 2015))

Biomatrix Neoflex™ DES, Biomatrix Alpha™ DES and Biostream DEB complete our portfolio.



SMT is a leading developer and manufacturer of minimally invasive coronary stent systems. We have a strong international presence with global footprints in more than 80 countries with proven Safety & Efficacy.

SMT is the First company in the world to receive the CE certification for DES with biodegradable polymers which became a ‘trend’ thereafter.  SMT now has its European headquarters in Galway with a full fledged R&D centre in addition to the Drug Kinetics and Design R&D operations in India.

TALENT – Randomised Trial of Supraflex Ultrathin stents against Xience family is successfully completed in Europe and 12 months follow up results were presented at TCT San Diego 2018.



 HeartFlow, Inc. is a medical technology company transforming the way heart disease is diagnosed and treated. Our non-invasive HeartFlow Analysis leverages deep learning to create a personalized 3D model of the heart. By using this model, clinicians can better evaluate the impact a blockage has on blood flow and determine the best treatment for patients. The HeartFlow Analysis is commercially available in the United States, Canada, Europe and Japan.



Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anaesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference.



Merit Medical Systems, Inc. is a worldwide company engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures.  Our innovative products are designed to support procedures for the treatment of coronary and peripheral vascular disease from start to finish. We offer an integrated suite of interventional products to help optimize the efficiency of procedures.



ACIST is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. We are a global market leader in advanced contrast imaging systems for cardiovascular angiography with the CVi Contrast Injection System.  As part of the Bracco Group, ACIST benefits from the resources of a multinational conglomerate with broad expertise in cath lab technology and a dedication to continuous advancement.



 Edwards Lifesciences, based in Irvine, Calif., is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. For more information, visit and follow us on Twitter @EdwardsLifesci.



Exhibition Floor Plan

To download a copy of the exhibition floor plan, please use the link below.


File size: 470.00 Kb